Fingerprint
Dive into the research topics of 'Favorable Outcomes Combining Vedolizumab with Other Biologics or Tofacitinib for Treatment of Inflammatory Bowel Disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Ernesto M. Llano, Shreeju Shrestha, Ezra Burstein, Moheb Boktor, David I. Fudman
Research output: Contribution to journal › Article › peer-review